Target intelligence / Profile preview

Vaginal microbiota (Lactobacillus acidophilus colonization)

Molecular classification
Other (microbial community/ecosystem), Bacterium (for Lactobacillus acidophilus specifically)
01

Overview

The **vaginal microbiota** refers to the complex microbial community inhabiting the vagina, where **Lactobacillus species**, including *Lactobacillus acidophilus*, are key dominant members in healthy women—comprising up to 95% in optimal states. These bacteria play crucial roles by producing lactic acid that maintains low pH (<4.5), creating an environment hostile to many pathogens. *Lactobacillus* also produces hydrogen peroxide and antimicrobial peptides that further suppress harmful microbes. Colonization with beneficial lactobacilli is associated with reduced risk for bacterial vaginosis and other infections due to both direct inhibition through competitive exclusion at epithelial surfaces and indirect effects via modulation of host immune responses—including downregulation of proinflammatory cytokines. The ability to adhere effectively is mediated by surface proteins such as S-layer protein A (SlpA) in *L. acidophilus*, which are essential for stable colonization. Disruption or loss of these protective communities can lead to increased susceptibility to infection and inflammation. **Note:** "Vaginal microbiota via Lactobacillus acidophilus colonization" is not a canonical molecular target like a receptor or enzyme but rather describes an ecological state/process involving microbial populations within the vagina—specifically emphasizing beneficial colonization by *Lactobacillus* spp., including *L. acidophilus*. Therefore, it does not fit standard definitions used for drug targets such as receptors or enzymes; instead it represents a therapeutic strategy/goal rather than a discrete molecular entity. > “This report provides experimental evidence supporting the concept that the vaginal microflora regulates epithelial innate immunity...and that topically applied microbicides may alter both bacterial and epithelial components...” > “There are many microbial colonizations in the vagina...among which Lactobacillus plays a major role...can produce lactic acid...acidify the vaginal environment...and inhibit growth...” > “An important mechanism for protection from BV recurrence is vaginal acidity, which is largely a function of lactic-acid production by lactobacilli.”

Other names
Vaginal microfloraVaginal microbiomeLactobacillus acidophilus (as a component)L. acidophilus-colonized vaginal flora
02

Mechanism of action

For probiotics targeting this ecosystem or using L. acidophilus as an active agent: Competitive exclusion/colonization resistance against pathogens by occupying adhesion sites on the epithelium; Acidification via lactic acid production to inhibit pathogen growth; Induction/modulation of host innate immunity and anti-inflammatory cytokines.

03

Biological functions

Maintenance of vaginal pH and acidityInhibition of pathogenic bacteria and virusesModulation of local immune response and inflammationProduction of lactic acid, hydrogen peroxide, antimicrobial peptides
04

Disease associations

Infection (protection against bacterial vaginosis, sexually transmitted infections)Other (maintenance of mucosal health, prevention of dysbiosis)
05

Safety considerations

Potential failure to establish colonization after treatment cessation leading to recurrence risk for conditions like BVPossible alteration or disruption by antibiotics, sexual activity, hygiene practices affecting efficacy/safety profileNo major safety concerns reported with established probiotic strains such as NCFM; generally considered safe as a biotherapeutic platform
06

Interacting drugs

Probiotic formulations containing Lactobacillus species (Example: LACTIN-V containing L. crispatus CTV05; no direct mention for L. acidophilus in the context of approved drugs for vaginal use but used in research/probiotic supplements)
07

Biomarkers

Vaginal pH (<4.5 indicates healthy lactobacilli dominance)Quantitative PCR for Lactobacillus species abundance in vaginal samples

Beyond the preview

Go deeper on Vaginal microbiota (Lactobacillus acidophilus colonization).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal microbiota (Lactobacillus acidophilus colonization).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call